Acute leukaemia in children: Diagnosis and management

BMJ (Online)

Volumn 338, Issue 7709, 2009, Pages 1491-1495

  Mitchell, Chris ^a   Hall, Georgina ^a   Clarke, Rachel T ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; AIRWAY OBSTRUCTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; BLOOD EXAMINATION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ASSESSMENT; DRUG DOSE TITRATION; EVENT FREE SURVIVAL; FERTILITY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; LIVER TOXICITY; LUNG EDEMA; LUNG HEMORRHAGE; MENINGOCOCCEMIA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STEM CELL; STROKE; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT DURATION; WHOLE BODY RADIATION;

EID: 67650092721     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2285     Document Type: Review

References (23)

1. Draper GJ, Stiller CA,O'Connor CM, Vincent TJ, Elliott P, McGale P, et al. The geographical epidemiology of childhood leukaemia and non-Hodgkin lymphomas in Great Britain, 1966-83. OPCS studies on medical and population subjects, no 53. London: OPCS, 1991.
2. Feltblower RG, Lewis IJ, Picton S, Richards M, Glaser AW, Kinsey SE, et al. Diagnosing childhood cancer in primary care - a realistic expectation? Br J Cancer 2004;90:1882-4.
3. Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 2005;129:734-45.
4. Matloub YH, Angiolillo A, Bostrom B, Stork L, Hunger SP, Nachman J, et al. J Clin Oncology 2007;25(18S):9511.
5. Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-43.
6. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349:344-9.
7. SEER Cancer Statistic Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2000:467.
8. Ries LA, Smith MA, Gurney JG. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. SEER Pediatric Monograph.
9. Horwitz M. The genetics of familial leukemia. Leukemia 1997;11:1347-59.
10. Hasle H, Clemmensen IH,Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355:165-9.
11. Kinlen LJ. Infections and immune factors in cancer; the role of epidemiology. Oncogene 2004;23:6341-8.
12. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006;6:193-203.
13. Redalli A, Laskin BL, Stephens JM, Boteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care 2005;14:53-62.
14. Alvarez Y, Caballin MR, Gaitan S, Perez A, Bastida P, Ortega JJ, et al. Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangement. Cancer Genet Cytogenet 2007;177:161-3.
15. Chessells JM. Pitfalls in the diagnosis of childhood leukaemia. Br J Haematology 2001;114:506-11.
16. Frankfurt O, Tallman M. Emergencies in acute lymphoblastic leukaemia. In: Estey EH, Faderl SH, Kantarjian HM, eds. Hematologic malignancies: acute leukaemias. Berlin: Springer, 2008:281-8.
17. Harrison CJ, Kempski H, Hammond DW, Kearney L. Molecular cytogenetics in childhood leukemia. Methods Mol Med 2003;91:123-37.
18. Rubnitz JE, Evans WE. Pathobiology of acute lymphoblastic leukaemia. In: Hoffman R, Benz Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al eds. Hematology, basic principles and practice. New York: Churchill Livingstone, 2000:1052-69.
19. Campana D. Role of minimal residual disease evaluation in leukaemia therapy. Current Hematologic Malignancy Reports 2008;3:155-60.
20. Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM, et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia 2000;14:2307-20.
21. Hann IM, Webb DK, Gibson BE, Harrison CJ. MRC trials in childhood acute myeloid leukaemia. Annals Hematol 2004;83:S108-12.
22. Pizzo P. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
23. Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised child. Best practice statement. 2002. www.rcpch.ac.uk/doc. aspx?id-Resource=1768.